Monday, February 14, 2022

Pfizer Reports $37 Billion In COVID Vaccine Sales In 2021

Pfizer has reported nearly $37 billion in COVID vaccine sales in just 2021 alone. The CEO of Pfizer noted that COVID extermination is improbable, with several scientists earlier suggesting that newer vaccines were adding to the rise of variations.

In 2021, Pfizer claimed $36.78 billion in worldwide sales and alliance revenue from their abortion-tainted COVID vaccination, leading to more than double earnings across its business activities contrasted to 2020.

In an earnings report released Tuesday, the pharmaceutical behemoth predicted that revenues of its vaccine and antiviral medication would reach $54 billion in 2022, boosting investors’ expectations that profits would rise for the second year running.